Understanding how specific RNA elements control protein production in cancer cells
Translational control by 5'-UTR elements
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11248456
This study is looking at how certain parts of RNA help control protein production in cancer cells, which could lead to new treatments that improve how cancer affects the body.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11248456 on ClinicalTrials.gov |
What this research studies
This research investigates the role of 5'-untranslated regions (5'-UTRs) in regulating protein synthesis, particularly in cancer cells. By examining how these RNA elements influence the recruitment of ribosomes, the study aims to uncover the mechanisms that lead to variations in protein output. The approach combines advanced biochemical techniques and genetic studies to identify key components that affect translation activity. Patients may benefit from insights gained into how cancer alters protein synthesis, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer, particularly those whose tumors exhibit changes in 5'-UTR usage.
Not a fit: Patients with non-cancerous conditions or those not exhibiting alterations in protein synthesis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatments targeting protein synthesis in cancer, improving patient outcomes.
How similar studies have performed: Previous research has shown that understanding RNA elements can lead to significant advancements in cancer treatment, indicating a promising avenue for this investigation.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NIEDERER, RACHEL O. — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: NIEDERER, RACHEL O.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.